Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Nosocomial pneumonia].

S Ewig1, P Walger, H Vetter

  • 1Medizinische Universitäts-Poliklinik, Bonn. santiago.ewig@ukb.uni-bonn.de

Therapeutische Umschau. Revue Therapeutique
|November 7, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The plasminogen activator inhibitor 1 4G/5G polymorphism is not associated with longevity: a study in octogenarians.

Journal of molecular medicine (Berlin, Germany)·2001
Same author

[An uncommon cause of severe soft tissue bleeding during phenprocoumon treatment].

Deutsche medizinische Wochenschrift (1946)·2001
Same author

Clinical differences between benign and malignant pheochromocytomas.

Endocrine journal·2001
Same author

Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2001
Same author

[Chronic progressive polycythemia and thrombocytosis].

Praxis·2001
Same author

Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.

Cancer research·2001
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Nosocomial pneumonia, often seen in ventilated patients, has distinct microbial causes based on onset time. Early onset pneumonia typically involves Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae, while late onset pneumonia includes gram-negative bacteria and resistant organisms.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Context:

  • Nosocomial pneumonia is a significant complication, especially in mechanically ventilated patients.
  • Microbial patterns vary based on the time of pneumonia onset.
  • Individual risk factors can alter typical microbial patterns.

Purpose:

  • To outline the diagnostic work-up for nosocomial pneumonia.
  • To identify common and emerging pathogens based on onset time.
  • To guide empirical antimicrobial treatment strategies.

Summary:

  • Early onset pneumonia (≤4 days) is often caused by Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae.
  • Late onset pneumonia (>4 days) additionally involves gram-negative Enterobacteriaceae and potentially drug-resistant microorganisms.

Related Experiment Videos

  • Diagnostic evaluation requires assessing severity, confirming pneumonia, identifying pathogens, and interpreting results within the clinical context.

    • Impact:

    • Informs empirical antimicrobial treatment choices for both ventilated and non-ventilated patients.
    • Highlights the need for reevaluation in cases of antimicrobial treatment failure.
    • Contributes to improved management strategies for hospital-acquired pneumonia.